Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Exercise training with dapagliflozin in adults with type 2 diabetes
2019-004586-41Phase 4Unknown
- Sponsor
- University of Leicester
- Start
- Aug 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of dapagliflozin in type 2 diabetes mellitus (T2DM) (3 arms), sponsored by University of Leicester. Primary endpoint: Change in physical function. Status: unknown.
02
Drugs
dapagliflozin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2019-004586-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-004586-41.